GELS Short Volume

Gelteq Limited Ordinary Shares (GELS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $4.0M, listed on NASDAQ, employing roughly 7 people, carrying a beta of 0.08 to the broader market. Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. Led by Nathan Jacob Givoni, public since 2024-10-29.

Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.

Latest Date

2026-06-01

Short Volume

3.3K

Total Volume

9.1K

Short %

36.06%

30-Day Avg Short %

35.06%

Showing 30 days of FINRA short volume data for Gelteq Limited Ordinary Shares.

Learn how short volume is reported and how to read the data →

Frequently asked GELS short volume questions

What is the daily GELS short volume?

As of Jun 1, 2026, Gelteq Limited Ordinary Shares (GELS) short volume is 3.3K shares against 9.1K total reported volume, or 36.06% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.

How is GELS short volume reported?

FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.

What does GELS short volume tell options traders?

Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.